Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

http://scihub22266oqcxt.onion/ 33380117!ä!33380117       Vnitr+Lek 2020 ; 66 (7): 402-408 Nephropedia Template TP {{tp|p=33380117|t=2020. Koagulopatie asociovana s onemocněnim COVID-19 |pdf=|usr=}}{{33380117}} gab.com Text Koagulopatie asociovana s onemocněnim COVID-19 JO: Vnitr Lek http://www.kidney.de/pget.php?&tw=1&pmid=33380117 #FOAvip Infection with a new type of coronavirus surprised with the diversity of its clinical symptoms. The disease may be asymptomatic, with only mild symptoms in the form of olfactory loss, general weakness or flu-like symptoms. However, in some patients, COVID-19 infection can be severe, with hypercoagulation being a common finding, with vascular endothelial damage and the consequent risk of venous and arterial thrombotic complications. Coa-gulopathy subsequently significantly worsens the prognosis of patients and increases overall mortality. Recently, a new term has been introduced to indicate the presence of activated hemostasis in SARS-CoV-2 infection - coagulopathy associated with COVID-19 (CAC). The current global pandemic of COVID-19 has triggered intensive research on the disease, which has clarified a number of findings about the infection, but we still have many unanswered questions, especially regarding possible treatment. Twit Text FOAVip Koagulopatie asociovana s onemocněnim COVID-19 ????Vnitr Lek http://www.kidney.de/pget.php?&tw=1&pmid=33380117 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=33380117 #FOAvip English Wikipedia <ref>{{Cite pmid|33380117}}</ref> Koagulopatie asociovana s onemocněnim COVID-19 #MMPMID33380117 Bilkova S; Hirmerova J Vnitr Lek 2020[Fal]; 66 (7): 402-408 PMID33380117show ga Infection with a new type of coronavirus surprised with the diversity of its clinical symptoms. The disease may be asymptomatic, with only mild symptoms in the form of olfactory loss, general weakness or flu-like symptoms. However, in some patients, COVID-19 infection can be severe, with hypercoagulation being a common finding, with vascular endothelial damage and the consequent risk of venous and arterial thrombotic complications. Coa-gulopathy subsequently significantly worsens the prognosis of patients and increases overall mortality. Recently, a new term has been introduced to indicate the presence of activated hemostasis in SARS-CoV-2 infection - coagulopathy associated with COVID-19 (CAC). The current global pandemic of COVID-19 has triggered intensive research on the disease, which has clarified a number of findings about the infection, but we still have many unanswered questions, especially regarding possible treatment. |*Blood Coagulation Disorders/etiology[MESH] |*COVID-19[MESH] |*Coronavirus Infections/epidemiology[MESH] |Humans[MESH] |Pandemics[MESH]Koagulopatie asociovana s onemocněnim COVID-19 (epmc).pdf DeepDyve Pubget Overpricing